Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scientific Advisory Board Houston, TX, USA, March 8, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston, Texas,…
Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development Houston, TX, USA, March 1st, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston,…
Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Houston, Texas, USA – January 6th, 2022 (GLOBE NEWSWIRE) –…
Houston, Texas, USA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development…
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…
Invectys Inc. to participate in the 2022 JP Morgan Healthcare Meeting and Biotech Showcase, January 10-19, 2022 Houston, Texas, USA January 5th, 2022 (GLOBE…
Invectys Inc. to participate in the 2021 Roth Virtual Healthcare Private Company Forum on June 28th, 2021 Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) –…
Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 1st, 2021 (GLOBE NEWSWIRE) — Invectys…
